Teva Pharm announces approval of Terbinafine HCL tablets

Tue Jul 3, 2007 8:39am EDT

Co announces that the FDA has granted final approval for the co's Abbreviated New Drug Application to market Terbinafine Hydrochloride Tablets, 250 mg, the AB-rated generic equivalent of Novartis' antifungal agent Lamisil Tablets. Shipment of this product will begin immediately.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.